Skip to main content
Clinical Trials/IRCT201102065775N1
IRCT201102065775N1Completed未知

ormobaric hyperoxia preconditioning ameliorates cisplatin nephrotoxicity: a pilot prospective case-control study

ephrology and Urology Research Center, Baqiyatallah University of Medical Sciences0 sites21 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
21

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • the patients who treated with cisplatin due to cancer
  • Exclusion criteria: The patients who had chronic obstructive lung disease, pneumothorax, upper respiratory infection, fever, viral infection, history of seizure, optic nerve inflammation, history of ear surgery and history of heavy cigarette smoking were excluded from this study. None of female patients was pregnant.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
ephrology and Urology Research Center, Baqiyatallah University of Medical Sciences

Similar Trials